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Bio-fluids are the source of a large number of metabolites. Identification and quantification of them can be an effi-
cient step for understanding the internal chemistry of the body as well as for developing objective diagnostics of dis-
eases. Several techniques have been developed so far; however, their metabolite identification and/or quantification
are not reliable enough for acceptance by clinicians. As another promising step in this direction, we push infrared
spectroscopy of bio-fluids in gas phase. Here we discuss features of breath and urine headspace realized with Fourier
transform infrared spectroscopy. Molecular identification procedures based on component analysis of gas samples
are proposed. In this paper, we show that aggregate data from different bio-fluids in gas phase can strengthen the
diagnostics of the body state and disease. © 2020 Optical Society of America
https://doi.org/10.1364/AO.388362
1. INTRODUCTION
Each and every living organism undergoes thousands of bio-
chemical reactions to maintain its life. The corresponding
chemical compounds circulating in the body can be considered
as messengers carrying information about its state [1]. Those
compounds are called metabolites and in general are restricted to
small organic molecules [2]. Metabolites become released from
the body via urine, feces, sweat, saliva, exhaled air, etc. Hundreds
of metabolites have been reported so far [3,4]. There is hope
that the above-mentioned bio-fluids can be used for analysis of
different body states including diseases [5]. Unfortunately, slow
progress in this direction shows that still there is a lack of robust
detection techniques capable of simultaneous identification of
a high number of molecules and their accurate quantification
[6,7]. We therefore push further the analysis of biological sam-
ples for molecular identification using vibrational spectroscopy.
Vibrational spectroscopy is well established as a powerful and
widely used tool for studying molecular structure and dynamics
in the fields of chemistry and physics [8,9]. It uses molecu-
lar bond vibrations as a probe to identify the composition of
the molecule and its 3D structure [10,11]. In recent years,
development of ultrafast lasers has made it possible to observe
the vibrational motion in real time [12]. This unique feature
facilitates revealing chemical and biological processes even on
a femtosecond (fs) timescale [13]. Therefore, it is natural to
expect that vibrational spectroscopy can be a powerful tool for
identification of metabolites in bio-fluids [14,15].
Vibrational spectroscopy uses infrared light to excite
molecular bonds and measure absorption of light during
their vibrations. Each chemical bond has a unique vibrational
energy [16,17]. Therefore, each molecule has a set of unique
spectral features in the infrared part of the spectrum. This set of
spectral features is called a fingerprint of the molecule [18]. The
molecular fingerprint is used to identify molecules from a mix-
ture of molecules in bio-fluid [19,20]. However, infrared spectra
in liquid phase in general yield broad low structured spectral
features, thus making molecular identification a difficult or even
impossible task. On the other hand, infrared spectra in gas phase
yield narrow spectral features of molecules, thus allowing their
identification to be much easier than liquid phase [21,22]. In
this study, we demonstrate and illustrate a technique that we
developed to analyze bio-fluids in gas phase.
The main advantage of the gas phase biological samples
analysis over the tissue or liquid phase biological samples is
that water can be removed from the sample without changing
the molecular constitution. A highly efficient water removal
technique was developed in our group and reported recently
[23]. In combination with the water removal technique, Fourier
transform infrared (FTIR) spectroscopy has already proved its
potential for breath analysis [6,24]. In this paper, we show how
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FTIR spectroscopy is used for analysis of gas-phase biological
samples including breath and urine headspace.
2. MATERIALS AND METHODS
A schematic of the experimental procedure aimed at revealing
molecular fingerprints is depicted in Fig. 1. The experimen-
tal setup consists of three major units, namely, (1) a sample
collector, (2) a water condenser, and (3) an infrared FTIR
spectrometer.
Before the sample collection, the complete system is evacu-
ated by vacuum pump to remove any trace of contamination.
Breath samples collected with Tedlar bags are transferred to
the empty sample collector by releasing the valve. In the case of
bio-fluid in liquid phase, it is collected in a specially designed
well-sealed sample container in such a way that only part of
the container is filled with bio-fluid in liquid phase. The sam-
ple is kept a sufficient time in the container to allow volatile
compounds in bio-fluid to escape it via sublimation creating
headspace, with their further collection. Finally, by releasing the
valve, a headspace sample goes to the empty sample collector.
Unlike breath, the headspace sample collection aimed at further
spectroscopic analysis still has no established standard operating
procedure (SOP).
A water condenser is a closed metal chamber containing a
12 m long, spiral copper tube, through which a gas sample is
moved from the sample collector to a multipass gas cell attached
to a FTIR spectrometer. The chamber is filled with a special
liquid operating at temperatures between −95◦C and +45◦C.
Before the gas sample is allowed to pass through the water
condenser, the liquid is cooled to −60◦C by the refrigerated
circulator. Then the gas sample is allowed to pass through the
spiral tube with a precisely controlled flow rate of 3 ml/s. A large
amount of water vapor is removed from the gas sample when
it passes through the cold copper tube. A reduction of approx-
imately a factor of 2500 is achieved for the breath sample at
−60◦C. Finally, the water suppressed gas sample is transferred to
the multipass gas cell, attached to the FTIR spectrometer. After
each experiment, the copper tube is cleaned by heating with the
heat circulator and vacuum pump. A detailed description of
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Fig. 1. Schematic of the experimental scheme, with three main
parts: (1) collection—a collector, where breath or headspace of liquid
bio-fluids is collected; (2) preparation—a water suppressed sample
is prepared when gas-phase bio-fluids are passing through “the water
condenser”; (3) analysis—a water suppressed gas sample is collected to
the multipass gas cell and measured with a FTIR spectrometer.
the setup and its working principle was reported in a separate
article [23].
Finally, the water suppressed gas sample is collected in the 4 m
multipass cell, which is placed inside the Bruker Vortex70 FTIR
spectrometer. Spectral data are collected by a liquid nitrogen-
cooled mercury-cadmium-telluride (MCT) detector in a range
from 500 cm−1 to 4000 cm−1. Data are analyzed by component
analysis, which uses known molecular fingerprints for fitting the
observed spectral features.
Two experiments were performed: one that included a
single-case aimed at comparison of absorption spectra of breath
and urine headspace, and another aimed to find out statistical
differences in breath between healthy volunteers and patients
with cerebral palsy (CP). Breath and urine samples were col-
lected from a healthy volunteer in our working group. Twelve
persons with cerebral palsy (23–52 years), recruited from a
day care center for persons with disabilities, and 12 healthy
adults (25–77 years), recruited among the personnel working
at Ludwig Maximilian University (LMU), participated in this
study. For the participants with CP, the experimental proce-
dures were approved by the ethics committee of the Faculty
of Medicine of the Technical University of Munich, and for
the healthy participants, from the ethics committee of LMU.
Participation in the study was voluntary, and all subjects, or in
some cases, their legal protectors, gave their written informed
consent before the sample collection. Each breath sample
was collected in a single-use 1 liter Tedlar bag via multiple
exhalations of normal breathing [6].
3. RESULTS AND DISCUSSION
It is a common practice in medical studies that collected data are
analyzed statistically. Most commonly used statistical methods
are unsupervised ones such as principal component analysis
(PCA) often combined with analysis of variance (ANOVA),
as well as supervised ones such as random forest, etc. For these
methods, experimental data are analyzed blindly, i.e., no certain
spectral features can be attributed to the result. Hence, in some
cases, the method of choice cannot distinguish between real
data variations and experimental noise or measurement errors,
thus leading to misinterpretation of the data. We proposed and
successfully tested the component analysis, where each spectral
component is matched with a known molecular spectral feature
(reference fingerprint). The reference spectra were collected
from PNNL, HITRAN, or NIST databases [25,26]. However,
in many cases, when fine structure features are required to dis-
tinguish between several molecular candidates, digital spectra
have been collected experimentally from the same spectrometer
by applying the same spectral resolution used for the breath
spectra [7]. Only in the case of matching was a spectral compo-
nent considered for further analysis. The peak strength of the
identified spectral feature (i.e., absorbance) can be transferred
into the corresponding concentration and used then to quantify
the state of the body. A detailed analysis of the body state made
with such a procedure was reported in a separate article [6].
The FTIR spectrum of breath of a healthy volunteer is
presented in the top panel of Fig. 2. Only water and CO2
absorption peaks can be observed. To note, CO2 is produced
in many biological processes in the body and therefore is not
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Fig. 2. Top: FTIR spectra of a breath sample of a healthy volunteer without water suppression. Bottom: water suppressed breath spectrum of the
same healthy volunteer. The y axis in the top panel is 103 times larger than that in the bottom panel. Inset: zoomed carbon monoxide absorption spec-
trum. A few fingerprints are identified and labeled.
specific enough for detailed analysis of the body state. All other
spectral signatures of volatile organic compounds (VOCs) are
buried mostly under the water absorption. The typical water
suppressed breath spectrum of the same healthy volunteer is
presented in the bottom panel of Fig. 2. A large amount of water
suppression (a factor of 2500) makes the spectrum cleaner,
especially in the range from 1100 to 2000 cm−1 and 3000 to
4000 cm−1. We expect that other than water and CO2, small
(not more than 120 atomic units) VOCs can be specific for
certain diseases, leading thus to distinct statistical spectral
differences between the groups under study. The main task
of the analysis of biological samples in gas phase is to identify
those particular VOCs and to find their origin and a trans-
portation scheme in the body. In this paper, we discuss only the
identification of VOCs.
Now, let us discuss the most promising spectral regions with
distinct features that we observed. The spectral range from 2800
to 3200 cm−1 is populated mostly with C–H stretch vibrational
absorption bonds [27,28]. The C–H bond is the characteristics
of biological molecules; therefore, all of them contribute to
this spectral region, resulting in a congested spectral structure.
It means that, practically, it is difficult to identify individual
molecules with their fingerprints in this region. However, a
distinguished spectral feature observed around 3100 cm−1 was
identified as the R branch of methane. A very strong Q branch
of methane is observed around 3020 cm−1; however, the P
branch is buried under broad C–H absorption spectra of other
biological molecules and still cannot be revealed.
Many prominent spectral features are observed in the spectral
range between 900 and 1800 cm−1. The features are relatively
less congested, making the identification of the corresponding
molecules easier [7]. For example, a double-peak structure
around 900 cm−1 is a unique feature of isoprene produced in
the human body via cholesterol biosynthesis [29,30]. The peak
at 1220 cm−1 is a clear signature of acetone, identified unam-
biguously. However, the peak at 1375 cm−1, which is also a
fingerprint of the acetone molecule, is a bit higher in absorbance
strength than it should be in relation to other peaks. Therefore,
this spectral feature must be a product of several molecules.
Acetaldehyde also yields an absorption peak there, thus con-
tributing to the observed peak at 1375 cm−1 [7]. Very strong
absorption is observed around 1750 cm−1 due the C=O bond
of acetone, aldehyde, and some small molecule with the amide
band.
The identified molecules mentioned above are present in the
breath of a healthy volunteer with relatively high concentra-
tion, between a few hundred ppb (parts per billion) and a few
ppm (parts per million). However, many more molecules are
present in human breath at lower concentrations. In the current
state, the detection limit of our gas analysis system is about
40 ppb [23]. Therefore, still there is a chance to identify more
molecules with the setup shown in Fig. 1. With a proper zoom
of the spectra, more molecules can be found on the pedestal of
the above-mentioned peaks. For example, with a ×10 zoom, a
distinct fine structure becomes visible (see inset in Fig. 2) at the
pedestal of the left shoulder of the carbon dioxide peak around
2300 cm−1. This fine structure is identified as the absorption
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Fig. 3. (a) Average breath spectra of CP and healthy volunteers in the spectral range between 1180 and 1200 cm−1. (b) Illustration of statistical
component analysis of patients with CP and matched healthy individuals made in the spectral range of 1180 to 1200 cm−1. A vertical scale shows the
average concentrations of the metabolites, and the plot boxes show data deviations from the mean value for the two groups.
signature of carbon monoxide [31] produced in the human
body due to catabolic processes, oxidative stress, and tissue
injury [32]. Similarly, using a higher zoom and careful inves-
tigation, many more molecules can be identified [7]. So far, a
few VOCs have been identified; however, many more revealed
spectral features are on the way of their identification.
To illustrate how the measurement and identification steps
can be realized in a real biomedical experiment, here we present
the result of our pilot study that has been carried out for a group
of patients with CP. For statistical comparison, the number
of volunteers in the reference healthy group and their average
age and gender ratio were comparable to those in the group
of patients with CP. A distinguished spectral feature has been
observed around 1189 cm−1. The average spectra of healthy and
CP persons are presented in Fig. 3(a). The result of the statistical
analysis provided in the most sensitive spectral range of 1180
to 1200 cm−1 is shown in Fig. 3(b) [7,33]. The red lines in the
gray boxes are average spectral strength at the spectral position
1189 cm−1 for CP and healthy volunteer groups. It is clear from
the box plot that CP and healthy groups are clearly distinguish-
able. A conventional statistical analysis based on unsupervised
PCA (PCA + ANOVA) demonstrated data clustering for the
healthy and CP groups, with the p-value below 10−5. A super-
vised analysis (support vector machine and random forest)
resulted in approximately 91% accuracy of distinguishing the
corresponding groups.
Breath is only one example of bio-fluid in gas phase. Another
example is urine headspace, which can also be collected nonin-
vasively [34]. The absorption spectrum of the urine headspace
accompanied with water suppression was collected in the range
of 500 to 4000 cm−1. The spectrum is also populated with
many characteristic molecular features, and a few of them are
common molecular features observed in the breath sample.
However, the common features in the two types of samples
appear in very different relative and absolute concentrations.
For comparison, both spectra are plotted in Fig. 4. The most
striking difference is the CO2 absorption peak, which saturates
the detector in the case of the breath sample, but appears at
a significantly lower level in the case of the urine headspace
sample. Due to the significantly lower concentration of CO2, a
fingerprint of alcohol is revealed in the urine headspace spectra
(see the left inset in Fig. 4). Similarly, carbon monoxide that
appears in breath at the pedestal of the left shoulder of the CO2
peak at 2175 cm−1 can be observed in a clear spectral window in
urine.
Another striking difference can be seen for the isoprene
absorption spectrum. Urine contains a significantly higher
amount of isoprene than that in breath. Isoprene is slightly
too big to easily escape the bloodstream through the alveolar
membrane, but easily leaves the urine sample. Various lines of
supportive evidence suggest that isoprene is related to choles-
terol biosynthesis [30]. Therefore, its measurements could
potentially be used for monitoring lipid disorders and could
serve as an additional parameter to complement invasive tests
for monitoring the efficacy of lipid-lowering therapy, pharmaco-
logical and dietary or lifestyle [35]. Therefore, in the case of lipid
disorder diagnostics, the urine sample would be advantageous
over the breath sample.
The spectral feature around 1800 cm−1 in the urine
headspace spectrum is not observed in the breath spectrum.
This peak is identified as the amide I band of anhydride amino
acids [22]. Though we still do not attribute it to a certain amino
acid, monitoring of the level of amino acids in general will allow
researchers to say more about the body state. Another peak is
observed around 3100 cm−1. This peak is also not assigned to
a molecule; however, definitely this is not methane, since there
is no Q branch observed. On the contrary, methane is always
observed in the breath sample. A possible explanation of that
is based on the small molecular size of methane. Because of
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Fig. 4. Absorption spectrum of water suppressed urine headspace
(red) plotted together with the breath absorption spectrum (blue)
of a healthy volunteer. Fingerprints of alcohol and CO from urine
headspace are presented in inset. A few fingerprints are labeled.
E40 Vol. 59, No. 17 / 10 June 2020 / Applied Optics Research Article
this, methane easily escapes the bloodstream via alveoli, and
nothing remains to escape via the kidney. Similarly, several other
small molecules such as acetone, aldehyde, etc., are observed
in breath but absent in urine. From this short comparison, we
see that in terms of available information, urine headspace is
not a competitor of breath. Rather, considered together, they
enrich the body diagnostics. Moreover, the infrared detection
technique that we have developed for breath analysis is capable
of handling both breath and urine samples simultaneously.
Moreover, other bio-fluids such as saliva, blood, sweat, etc., can
be analyzed via headspace sampling. To the best of our knowl-
edge, the headspace of bio-fluids has not been analyzed so far via
infrared spectroscopy.
4. CONCLUSION
In this paper, a spectroscopic analysis technique of bio-fluids
has been presented. Several important issues of analysis of gas
samples of biological fluids via FTIR spectroscopy have been
pointed out and discussed. The spectroscopy was used to record
the absorption spectra of the water suppressed urine headspace
and breath samples. The molecular fingerprint-based spectral
analysis was used to identify the VOCs in gas phase. We found
that a significant number of volatile metabolites appears in
the headspace of urine as well as in breath. Many of them are
common for urine and breath, however, present in different
absolute and relative concentrations. For example, isoprene is
present for both samples, but in urine, it is present at a much
higher concentration than in breath. On the contrary, breath
contains a large amount of acetone in comparison to urine
headspace. So far, only a few VOCs have been identified with
infrared spectroscopy, and many more observed absorption
peaks should be identified. We show that urine headspace analy-
sis is rather complementary to breath analysis, together making
the diagnostics via infrared spectroscopy more powerful. Since
the experimental technique that we developed is suitable for
extraction of headspace from any kind of liquid samples, the
spectroscopy-based diagnostics can be enriched via blood,
saliva, sweat, etc.
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